UNITED/
NEWS CANADA
≤ 5 MIN
Science

White House Withdraws CDC Director Nominee David Weldon

The Trump administration has withdrawn Dr. David Weldon’s nomination to lead the CDC, citing a lack of Senate support and his controversial anti-vaccine stance.

UNC
UNC Newsdesk
ONLINE
1 MIN
PUBLISHED MAR 13, 2025
White House Withdraws CDC Director Nominee David Weldon
THE FACTS /
  • The White House withdrew Dr. David Weldon's nomination for CDC director.
  • The Senate Health Committee canceled a planned confirmation hearing following the withdrawal.
  • Weldon is closely aligned with Health Secretary Robert F. Kennedy Jr. and has criticized vaccines.
  • This is the third failed Trump administration nomination, after Matt Gaetz and Chad Chronister.
  • Sources cite a lack of sufficient Senate votes for confirmation as the reason for withdrawal.

The White House has officially withdrawn the nomination of Dr. David Weldon, a former Florida congressman, to serve as director of the Centers for Disease Control and Prevention (CDC). The decision was announced Thursday morning, prompting the Senate Health Committee to cancel a scheduled confirmation hearing.

According to a source familiar with internal deliberations, the withdrawal occurred because it became evident that Weldon did not command enough votes in the Senate to secure confirmation. This marks the third high-profile nomination failure for the Trump administration, following the withdrawals of Matt Gaetz for attorney general and Chad Chronister for the Drug Enforcement Administration.

Weldon’s candidacy faced significant scrutiny due to his long-standing alignment with Health Secretary Robert F. Kennedy Jr., a prominent figure in the anti-vaccine movement. As a former congressman, Weldon has been a vocal critic of both vaccines and the CDC itself, an agency tasked with monitoring vaccine safety and promoting public health measures.

The combination of his ideological positions and the political reality of Senate confirmation prospects led to the abrupt end of his consideration for the role. The withdrawal underscores the challenges the administration faces in filling key public health leadership positions amid deep partisan divisions over medical policy.

ABOUT THIS STORY
This story was prepared by the United News Canada newsdesk, which condenses international reporting into a read of five minutes or less.

Corrections: [email protected]